CLINICAL_TRIALS
trial_result
· 2012-09-25
Clinical Trial Update: Phase II Study of KW-0761 in Subjects With CCR4-positive Adult T-cell Leukemia-lymphoma [Phase 2]
Summary
A Phase II study of KW-0761 (mogamulizumab) in CCR4-positive adult T-cell leukemia-lymphoma has completed enrollment, with results posted in 2012. The sponsor i…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Adult T-cell Leukemia-lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2012-09-25